← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2020Last known activity
Sep 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT07030920CollaboratorPhase 2Sep 30, 2025
- NCT04334551Reponsible party - principal investigatorPhase 4May 1, 2020
- NCT04334551Lead sponsorPhase 4May 1, 2020
Details
- Last known activity
- Sep 30, 2025